GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (351)

Latest Posts

About This Stock More About This Stock
Week In Review: Columbia China Building $150 Million Hospital In Jiaxing
Article By: ChinaBio® Today
Saturday, August 26, 2017 12:49 PM EDT
Columbia China has begun construction on a $150 million 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province. The new hospital, which is Columbia's second in China, will open in 2019.
In this article: GSK, MRK, PFE, BIIB, ADRO
Week In Review: China VC/PE Funds Raising Capital At $30 Billion Rate In 2017
Article By: ChinaBio® Today
Saturday, August 5, 2017 12:43 PM EDT
China life science venture/private equity funds have raised $45 billion and invested $12 billion over the past 30 months. They closed $20 billion in new funds during 2016 and are on track to hit $30 billion this year.
In this article: GSK, HCM
Glaxo (GSK) Beats Q2 Earnings, Misses Sales
Article By: Zacks Investment Research
Wednesday, July 26, 2017 8:20 AM EDT
Sales in the quarter were driven by strong performance mainly in the Vaccines and Pharmaceuticals segments which were up 5% and 3% respectively at constant exchange rate. The Consumer Healthcare segments were flat.
In this article: GSK
Drug Stocks Q2 Earnings Releases On Jul 26: GILD, VRTX, GSK
Article By: Zacks Investment Research
Wednesday, July 26, 2017 5:49 AM EDT
Vertex is scheduled to announce results after the closing bell. Vertex’s average positive earnings surprise for the last four quarters is 406.25%. In the last reported quarter, Vertex posted a positive surprise of 225%.
In this article: GSK, GILD, VRTX Also: JNJ, LLY, NVS, BIIB
Merck Seen As Having Potential 'Category Killer' In HIV Market
Article By: The Fly
Wednesday, July 5, 2017 1:40 PM EDT
The growth of the overall HIV market is slowing "as Medicaid enrollment (spurred by the ACA) plateaus," wrote Citi analyst Andrew Baum today in a research note.
In this article: MRK, GSK, GILD Also: PFE, AZN, RHHBY, BAYRY, BMY, LLY


Latest Tweets for $GSK

No tweets yet!